Oral treatment of visceral leishmaniasis with miltefosine

By Sundar S.   Gupta L. B.   Makharia M. K.   Singh M. K.   Voss A.   Rosenkaimer F.   Engel J.   Murray H. W.  

Annals of Tropical Medicine and Parasitology, Vol. 93, Iss. 6, 1999-09 ,pp. : 589-597

Routledge Ltd

Access to resources Recommend Favorite

Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients

By Marques Nuno   Sa Rosa   Coelho Filomena   Oliveira Joaquim   Saraiva Da Cunha J.   Melico-Silvestre A.  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 6-7, 2008-01 ,pp. : 523-526

Informa Healthcare

Access to resources Recommend Favorite

Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature

By Collini P.   Premchand N.   Lockwood D.   Greig J.  

Annals of Tropical Medicine and Parasitology, Vol. 103, Iss. 5, 2009-07 ,pp. : 455-459

Maney Publishing

Access to resources Recommend Favorite

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine

By Kumar D.   Ramesh V.   Verma S.   Ramam M.   Salotra P.  

Annals of Tropical Medicine and Parasitology, Vol. 103, Iss. 8, 2009-12 ,pp. : 727-730

Maney Publishing

Access to resources Recommend Favorite

Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure

By Colakoglu Murat   Fidan Yaylali Guzin   Yalcin Colakoglu Nagihan   Yilmaz Mustafa  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 3, 2006-03 ,pp. : 208-210

Informa Healthcare

Access to resources Recommend Favorite